Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Antisense and RNAi Therapeutics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Antisense and RNAi Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Antisense and RNAi Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Tekmira Pharmaceuticals
Silence Therapeutics
Sirnaomics
Arbutus Biopharma
Isis Pharmaceuticals
Antisense Therapeutics
Roche
Alnylam Pharmaceuticals
Santaris
By Type:
RNA Interference
Antisense RNA
By End-User:
Hospital
Clinic
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antisense and RNAi Therapeutics Market
-
1.3 Market Segment by Type
1.3.1 Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2014 to 2026
1.3.2 Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026
1.4.2 Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Antisense and RNAi Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antisense and RNAi Therapeutics by Major Types
3.4.1 Market Size and Growth Rate of RNA Interference
3.4.2 Market Size and Growth Rate of Antisense RNA
4 Segmentation of Antisense and RNAi Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antisense and RNAi Therapeutics by Major End-Users
4.4.1 Market Size and Growth Rate of Antisense and RNAi Therapeutics in Hospital
4.4.2 Market Size and Growth Rate of Antisense and RNAi Therapeutics in Clinic
5 Market Analysis by Regions
-
5.1 Japan Antisense and RNAi Therapeutics Production Analysis by Regions
-
5.2 Japan Antisense and RNAi Therapeutics Consumption Analysis by Regions
6 Hokkaido Antisense and RNAi Therapeutics Landscape Analysis
-
6.1 Hokkaido Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
6.2 Hokkaido Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
7 Tohoku Antisense and RNAi Therapeutics Landscape Analysis
-
7.1 Tohoku Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
7.2 Tohoku Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
8 Kanto Antisense and RNAi Therapeutics Landscape Analysis
-
8.1 Kanto Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
8.2 Kanto Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
9 Chubu Antisense and RNAi Therapeutics Landscape Analysis
-
9.1 Chubu Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
9.2 Chubu Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
10 Kinki Antisense and RNAi Therapeutics Landscape Analysis
-
10.1 Kinki Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
10.2 Kinki Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
11 Chugoku Antisense and RNAi Therapeutics Landscape Analysis
-
11.1 Chugoku Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
11.2 Chugoku Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
12 Shikoku Antisense and RNAi Therapeutics Landscape Analysis
-
12.1 Shikoku Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
12.2 Shikoku Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
13 Kyushu Antisense and RNAi Therapeutics Landscape Analysis
-
13.1 Kyushu Antisense and RNAi Therapeutics Landscape Analysis by Major Types
-
13.2 Kyushu Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Tekmira Pharmaceuticals
14.1.1 Tekmira Pharmaceuticals Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Silence Therapeutics
14.2.1 Silence Therapeutics Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Sirnaomics
14.3.1 Sirnaomics Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Arbutus Biopharma
14.4.1 Arbutus Biopharma Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Isis Pharmaceuticals
14.5.1 Isis Pharmaceuticals Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Antisense Therapeutics
14.6.1 Antisense Therapeutics Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Roche
14.7.1 Roche Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Alnylam Pharmaceuticals
14.8.1 Alnylam Pharmaceuticals Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Santaris
14.9.1 Santaris Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
The List of Tables and Figures (Totals 112 Figures and 161 Tables)
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2014 to 2026
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Antisense and RNAi Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Antisense and RNAi Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antisense and RNAi Therapeutics by Different Types from 2014 to 2026
-
Table Consumption Share of Antisense and RNAi Therapeutics by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of RNA Interference
Figure Market Size and Growth Rate of Antisense RNA
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Antisense and RNAi Therapeutics by Different End-Users from 2014 to 2026
-
Table Consumption Share of Antisense and RNAi Therapeutics by Different End-Users from 2014 to 2026
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026
-
Table Japan Antisense and RNAi Therapeutics Production by Regions
-
Table Japan Antisense and RNAi Therapeutics Production Share by Regions
-
Figure Japan Antisense and RNAi Therapeutics Production Share by Regions in 2014
-
Figure Japan Antisense and RNAi Therapeutics Production Share by Regions in 2018
-
Figure Japan Antisense and RNAi Therapeutics Production Share by Regions in 2026
-
Table Japan Antisense and RNAi Therapeutics Consumption by Regions
-
Table Japan Antisense and RNAi Therapeutics Consumption Share by Regions
-
Figure Japan Antisense and RNAi Therapeutics Consumption Share by Regions in 2014
-
Figure Japan Antisense and RNAi Therapeutics Consumption Share by Regions in 2018
-
Figure Japan Antisense and RNAi Therapeutics Consumption Share by Regions in 2026
-
Table Hokkaido Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Hokkaido Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Hokkaido Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Hokkaido Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Tohoku Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Tohoku Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Tohoku Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Tohoku Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Tohoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Kanto Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Kanto Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Kanto Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kanto Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Kanto Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Chubu Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Chubu Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Chubu Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Chubu Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Chubu Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Kinki Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Kinki Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Kinki Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kinki Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Kinki Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Chugoku Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Chugoku Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Chugoku Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Chugoku Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Chugoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Shikoku Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Shikoku Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Shikoku Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Shikoku Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Shikoku Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
-
Table Kyushu Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026
-
Table Kyushu Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Share by Types in 2014
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Share by Types in 2018
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Share by Types in 2026
-
Table Kyushu Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Kyushu Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018
-
Figure Kyushu Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Tekmira Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals
Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals
Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals
Table Product and Service Introduction of Tekmira Pharmaceuticals
Table Company Profile and Development Status of Silence Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics
Figure Sales and Growth Rate Analysis of Silence Therapeutics
Figure Revenue and Market Share Analysis of Silence Therapeutics
Table Product and Service Introduction of Silence Therapeutics
Table Company Profile and Development Status of Sirnaomics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics
Figure Sales and Growth Rate Analysis of Sirnaomics
Figure Revenue and Market Share Analysis of Sirnaomics
Table Product and Service Introduction of Sirnaomics
Table Company Profile and Development Status of Arbutus Biopharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma
Figure Sales and Growth Rate Analysis of Arbutus Biopharma
Figure Revenue and Market Share Analysis of Arbutus Biopharma
Table Product and Service Introduction of Arbutus Biopharma
Table Company Profile and Development Status of Isis Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Isis Pharmaceuticals
Figure Sales and Growth Rate Analysis of Isis Pharmaceuticals
Figure Revenue and Market Share Analysis of Isis Pharmaceuticals
Table Product and Service Introduction of Isis Pharmaceuticals
Table Company Profile and Development Status of Antisense Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisense Therapeutics
Figure Sales and Growth Rate Analysis of Antisense Therapeutics
Figure Revenue and Market Share Analysis of Antisense Therapeutics
Table Product and Service Introduction of Antisense Therapeutics
Table Company Profile and Development Status of Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
Figure Sales and Growth Rate Analysis of Roche
Figure Revenue and Market Share Analysis of Roche
Table Product and Service Introduction of Roche
Table Company Profile and Development Status of Alnylam Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
Table Product and Service Introduction of Alnylam Pharmaceuticals
Table Company Profile and Development Status of Santaris
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santaris
Figure Sales and Growth Rate Analysis of Santaris
Figure Revenue and Market Share Analysis of Santaris
Table Product and Service Introduction of Santaris
-
